The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Symptom burden, quality of life, and distress in acute myeloid leukemia patients receiving induction chemotherapy: A prospective electronic patient-reported outcomes study.
 
Thomas William LeBlanc
Honoraria - Helsinn Therapeutics
Consulting or Advisory Role - Boehringer Ingelheim; Epi-Q
Research Funding - Helsinn Therapeutics (Inst); Opus Science/Celgene (Inst)
 
Steven Wolf
No Relationships to Disclose
 
Debra M. Davis
No Relationships to Disclose
 
Greg Samsa
No Relationships to Disclose
 
Susan C. Locke
No Relationships to Disclose
 
Karen E. Steinhauser
No Relationships to Disclose
 
Peter A. Ubel
No Relationships to Disclose
 
James A. Tulsky
No Relationships to Disclose
 
Amy Pickar Abernethy
Employment - Advoset; AthenaHealth; Flatiron Health; Orange Leaf Associates
Leadership - AAHPM; AAHPM
Stock and Other Ownership Interests - AthenaHealth
Consulting or Advisory Role - ACORN Research; Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); DARA BioSciences (Inst); Dendreon (Inst); Galena Biopharma (Inst); GlaxoSmithKline (Inst); Helsinn Therapeutics (Inst); Insys Therapeutics (Inst); KangLaiTe (Inst); Pfizer (Inst)